Contact
searchSearch
HMP Global

News

News
Chewable Tablets Recalled
11/20/2024
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken...
11/20/2024
Pharmacy Learning Network
News
Supplement Pulled for Hidden Drug Ingredients
11/20/2024
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is...
11/20/2024
Pharmacy Learning Network
News
FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants
11/14/2024
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug...
11/14/2024
Pharmacy Learning Network
News
Opioid Analgesic Recalled
11/13/2024
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
11/13/2024
Pharmacy Learning Network
News
Prescription-Strength NSAID Recalled
11/13/2024
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling...
11/13/2024
Pharmacy Learning Network
News
Glass Particles Prompt Class I Recall for Injection
11/13/2024
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is...
11/13/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Impurity Prompts Two Firms to Recall Tablets
11/06/2024
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet...
11/06/2024
Pharmacy Learning Network
News
OTC Antihistamine Recalled
11/06/2024
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls...
11/06/2024
Pharmacy Learning Network
News
Antidepressant Recalled for Impurity
10/23/2024
Breckenridge Pharmaceutical Inc. is recalling 7107 bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Breckenridge Pharmaceutical Inc. is recalling 7107 bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Breckenridge Pharmaceutical Inc....
10/23/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use